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a b s t r a c t
Sialidases, enzymes that remove terminal sialic acid residues, are pivotal in various biological processes
such as malignancy and infection with pathogens. For histochemical staining of sialidase activity, we
have developed a new synthetic sialidase substrate, sialic acid-conjugated ﬂuorescent benzothiazolyl-
phenol derivative (BTP3-Neu5Ac), for rapid, sensitive, and speciﬁc ﬂuorescent staining of sialidase
activity. Here, we showed the usefulness of BTP3-Neu5Ac for histochemical ﬂuorescent staining of cells
infected with Sendai virus (SV), which possesses sialidase activity. BTP3-Neu5Ac also visualised SV-
infected regions of lung sections from SV-infected mice. We succeeded in histochemical ﬂuorescent
staining of SV both in vitro and in vivo. SV has been utilised in many virological and biotechnological
studies such as developments of an oncolytic virus, a gene therapy vector, and a vaccine candidate. BTP3-
Neu5Ac should contribute to rapid progress of such studies and researches on viral sialidase.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Sialidases also termed neuraminidases (enzyme code 3. 2. 1. 18)
are enzymes that catalyse removal of terminal sialic acid residues
such as α-D-N-acetylneuraminic acid (Neu5Ac) from glycoconjugates
(Miyagi and Yamaguchi, 2012). They are widely distributed in
mammals (Cross et al., 2012), bacteria (Connaris et al., 2009), viruses
(Plattet and Plemper, 2013; Suzuki et al., 1985; Takahashi et al.,
2010), and protozoa (Bermejo et al., 2013). Removal of sialic acid
induces protein conformational changes and electric charge changes,
resulting in regulation of biological processes such as endogenous
sialidase activity-dependent synaptogenesis (Isaeva et al., 2010),
cell malignancy caused by cellular sialidase overexpression (Koseki
et al., 2012; Tringali et al., 2012), uptake of apoptotic lymphocytes
(Meesmann et al., 2010), and loss of receptor binding sites of
pathogens (Bermejo et al., 2013; Plattet and Plemper, 2013; Suzuki
et al., 1985; Takahashi et al., 2010). Therefore, detection of sialidase
activity is important for the study of biological phenomena.
An immunochemical method using a speciﬁc anti-virus anti-
body has generally been used for visualisation of virus-infected
cells. However, it takes several weeks or months to prepare a
speciﬁc antibody of each virus or strain. Paramyxoviruses such as
Sendai virus (SV) and Newcastle disease virus show sialidase
activity (Suzuki et al., 1985). We assumed that a highly sensitive
sialidase substrate, which is deposited at the location of sialidase
activity by generating an insoluble ﬂuorescent compound, would
enable histochemical visualisation of virus-infected cells by an
easy protocol and in a short time, with no requirement for a
speciﬁc antibody and ﬁxation of cells.
Several methods for measurement of viral sialidase activity have
been established. In the thiobarbituric acid (TBA) assay, native
sialoglycoconjugates such as bovine fetuin and sialyllactose are
used as sialidase substrates. After sialic acid molecules have been
released from the sialoglycoconjugates by sialidase reaction, they
are oxidised and react with TBA to generate a red chromophore
(Nayak and Reichl, 2004; Romero et al., 1997). The TBA assay
has been widely used by virologists for measurement of viral
sialidase activity, but it is difﬁcult to examine sialidase activities of
many samples because of the complex multiple steps and arsenate
usage for the protocol of the assay. For representative ﬂuorescent
sialidase substrates, 4-methylumbelliferyl-Neu5Ac (4MU-Neu5Ac),
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1,2-dioxetane derivative of Neu5Ac (NA-STAR), and 5-bromo-4-
chloroindol-3-yl-Neu5Ac (X-Neu5Ac) have been mostly used
because of their commercial availability and an easy protocol of
one step. 4MU-Neu5Ac is divided by sialidase reaction into Neu5Ac
and soluble ﬂuorescent 4-methylumbelliferone (Nayak and Reichl,
2004; Takahashi et al., 2010). NA-STAR is a chemiluminescence-
based substrate that is highly sensitive and can be used to monitor
neuraminidase inhibitor-resistant inﬂuenza A viruses (Buxton et al.,
2000). However, these substrates cannot histochemically stain
sialidase activity. On the other hand, X-Neu5Ac forms an insoluble
compound by oxidation after sialidase reaction and can histochemi-
cally stain localisation of sialidase activity (Minami et al., 2011).
However, X-Neu5Ac has low sensitivity and easily detects unspe-
ciﬁc signals other than those from the infected cells such as signals
from inﬂuenza virus-infected cells (Suzuki et al., 2005) because it
requires a long time and high concentration to visualise sialidase
activity, which increase nonspeciﬁc signals derived from endogen-
ous cellular sialidase and progeny virus sialidase continuously
budded from the infected cells during reaction with X-Neu5Ac. To
enhance the sensitivity of X-Neu5Ac, a sensitiser such as Fast Red
Violet LB (FRV LB) as a coupler to form an azo dye is used with
X-Neu5Ac (Fujii et al., 1993; Saito et al., 2002; Suzuki et al., 2005).
However, nonspeciﬁc staining other than staining of the infected
cells is easily enhanced by FRV LB.
Since there has been no highly sensitive sialidase substrate with
an insoluble ﬂuorescent compound, we have developed a new
ﬂuorescent sialidase probe that is a useful tool for histochemical
visualisation of sialidase activity. A benzothiazolylphenol derivative
named BTP3 is a crystalline, insoluble, acid-resistant, and
ﬂuorescently-stable compound (Ex/Em¼372/526 nm) (Kim et al.,
2009; Minami et al., 2014; Otsubo et al., 2013). Its sufﬁciently large
Stokes' shift is advantageous for preventing effects of excitation light,
self-absorption, and noise ﬂuorescence derived from cells and
tissues. We have synthesised a BTP3 derivative (BTP3-Neu5Ac) that
was conjugated to Neu5Ac as a sialidase substrate. Although BTP3-
Neu5Ac itself is not ﬂuorescent, BTP3 should be locally deposited at
the location of sialidase activity after removal of Neu5Ac by sialidase
(Fig. 1). In our previous study, we showed that BTP3-Neu5Ac was
able to histochemically stain mammalian sialidase activity in tissue
sections (Minami et al., 2014). In the present study, we applied BTP3-
Neu5Ac to histochemical visualisation of SV sialidase activity.
SV, alternatively known as a murine parainﬂuenza virus,
belongs to the genus Respirovirus of the Paramyxoviridae family,
harbouring non-segmented negative sense RNA. Hemagglutinin-
neuraminidase (HN) glycoprotein and fusion (F) glycoprotein
are expressed on the virus envelope and play important roles in
SV invasion into host cells. HN glycoprotein recognises sialic acid
as a receptor and also shows sialidase activity at low pH. The
sialidase activity is thought to assist virus budding by removal of
sialic acid on the host cells and to prevent aggregation of virus
particles by removal of sialic acid on the viral surface glycopro-
teins. Both HN and F glycoproteins accumulate on the surface of
infected cells, being ready to produce progeny viruses (Faísca and
Desmecht, 2007; Kohama et al., 1981; Segawa et al., 2003; Suzuki
et al., 1985).
SV has been extensively studied as a pathogen against animals
and as an experimental material in biotechnology. SV infection is
highly contagious and mortal in rodents, causing severe pneumo-
nia and bronchiolitis. Once SV infection occurs, the virus spreads
rapidly to other sensitive animals. These animals die of SV
infection (Faísca and Desmecht, 2007). A large number of
researchers have expected that the high infectivity and cell
cytotoxicity of SV and no pathogenicity in humans can be taken
advantage of as an oncolytic virus and a vaccine candidate with
other antigens (Faísca and Desmecht, 2007; Morodomi et al.,
2012). Several detection systems have been established to detect
SV-infected cells for virological research and to provide proper
diagnosis of SV infection disease. The most widely utilised meth-
ods are plaque forming assays because a speciﬁc anti-SV antibody
is not required. Cells, such as Lewis-lung carcinoma monkey
kidney LLC-MK2 cells, are infected with clinical samples and
cultured in agarose gel-containing medium for several days until
the appearance of plaques. This method can be applied to
both measurement of SV infection titre and isolation of a cloned
virus (Sugita, 1981). Another diagnostic system is a serological
assay in which the anti-SV antibody titre in mouse serum is
examined with an enzyme-linked immunosorbent assay (ELISA)
(Zenner and Regnault, 2000). Reverse transcriptase-polymerase
chain reaction (RT-PCR) is also one of the choices, and it has
enabled detection of the SV gene with the highest sensitivity
(Wagner et al., 2003). Together with these existing methods, the
use of BTP3-Neu5Ac could contribute to the progress of virological
and biotechnological studies on SV, such as the development of an
oncolytic virus, gene therapy vector, and vaccine candidate.
In the present study, to establish a protocol of BTP3-Neu5Ac
usage for SV research, we attempted ﬂuorescently histochemical
visualisation of SV-infected cells through sialidase activity of HN
glycoproteins on the cell surface.
Results
Rapid and sensitive ﬂuorescent histochemical staining of SV sialidase
with BTP3-Neu5Ac
Firstly, we investigated the applicability of BTP3-Neu5Ac as a
substrate of SV sialidase. Detection of SV sialidase activity has been
performed at acidic pH (Segawa et al., 2003). To determine the
optimal pH for SV sialidase reaction with BTP3-Neu5Ac, a SV-
blotted polyvinylidenediﬂuoride (PVDF) membrane was treated
with BTP3-Neu5Ac at pH 4.5, 5.0, 5.5, or 6.0. The SV-blotted region
showed the strongest ﬂuorescence at pH 4.5 (Fig. 2A). Next, we
compared the sensitivity of BTP3-Neu5Ac against SV sialidase to
that of a conventional sialidase substrate, X-Neu5Ac. A serially
diluted SV-blotted PVDF membrane was treated with 10 μM BTP3-
Neu5Ac and 100 μM X-Neu5Ac. After substrate reaction for 10 min
at room temperature, BTP3-Neu5Ac clearly stained SV-blotted
regions until 2–2 hemagglutination units (HAU) (Fig. 2B). SV
dose-dependent ﬂuorescence with BTP3-Neu5Ac suggested that
BTP3-Neu5Ac was speciﬁcally reactive to SV. On the other hand,
Fig. 1. Fluorescent visualisation scheme of sialidase activity with BTP3-Neu5Ac.
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24-h incubation with X-Neu5Ac visualised SV blots, but 10-min
incubation did not (Fig. 2C). These results indicated that BTP3-
Neu5Ac was a much more rapid and more sensitive substrate than
X-Neu5Ac for SV sialidase.
Fluorescent visualisation of SV-infected cells with BTP3-Neu5Ac
We attempted ﬂuorescent histochemical visualisation of SV-
infected cells with BTP3-Neu5Ac. SV-infected LLC-MK2 cells at 24 h
after infection were treated with 10 μM BTP3-Neu5Ac at 37 1C for
5 min. Green ﬂuorescent staining was observed in a dose-dependent
manner of SV infection (Fig. 3A). To conﬁrm that the ﬂuorescence
was dependent on sialidase activity, the SV-infected cells were
treated with BTP3-Neu5Ac in the presence of 1 mM 2,3-dehydro-2-
deoxy-Neu5Ac (DANA), a pan-sialidase inhibitor. Fluorescence was
not generated under the condition of DANA treatment (Fig. 3B),
although the SV-infected cells were immunologically detected
(supplementary Fig. 1). This result indicated that generation of
ﬂuorescence by BTP3-Neu5Ac reaction was dependent on sialidase
activity of the SV-infected cells. We also conﬁrmed that the ﬂuores-
cence was dependent on SV sialidase activity by using Cos-7 cells
transfected with an expression vector coding the SV HN (HNsv) gene
or an empty vector. At 48 h post transfection, the cells were treated
with 10 μM BTP3-Neu5Ac at 37 1C for 5 min. Green ﬂuorescence was
observed in the cells transfected with the HNsv gene but not in the
cells transfected with the empty vector (Fig. 3C), indicating that
sialidase activity of HNsv produced the green ﬂuorescent staining
with BTP3-Neu5Ac treatment. To qualify the speciﬁcity of staining
with BTP3-Neu5Ac on SV-infected cells, we compared ﬂuorescent
histochemical staining with BTP3-Neu5Ac to immunohistochemical
staining with anti-SV antibody for detection of SV-infected cells. SV-
infected LLC-MK2 cells were ﬁxed with 4% paraformaldehyde and
immunostained, followed by 10 μM BTP3-Neu5Ac treatment. The
cells stained with BTP3-Neu5Ac were also immunostained with a
rabbit anti-SV polyclonal antibody (Fig. 3D). In order to compare the
sensitivities of BTP3-Neu5Ac and X-Neu5Ac, we tried to detect SV-
infected cells with X-Neu5Ac at 24 h post infection. SV-infected cells
were not stained by 5-min or 1-h treatment with 1 mM X-Neu5Ac.
Four-hour incubation with X-Neu5Ac resulted generation of a blue
pigment that covered the entire cell-cultured well, but staining of
SV-infected cells was not distinguished (supplementary Fig. 2). On
the other hand, SV-infected cells could be detected in 10 min by
using 10 mM BTP3-Neu5Ac, the concentration of which was much
smaller than that of X-Neu5Ac. Thus, BTP3-Neu5Ac could visualise
SV-infected cells more sensitively than X-Neu5Ac could. These results
showed that SV-infected cells were speciﬁcally stained with BTP3-
Neu5Ac.
Fluorescent histochemical visualisation of lung tissues
from SV-infected mice with BTP3-Neu5Ac
SV is known to infect mice and cause mortal respiratory
symptoms (Faísca and Desmecht, 2007). We planned ﬂuorescent
histochemical visualisation of SV-infected cells in lung sections
from virus-infected mice with BTP3-Neu5Ac. Female BALB/c mice
were intranasally challenged with SV. At 24 h post infection, lungs
of the infected mice were collected. After ﬁxation with 4%
paraformaldehyde, lung sections of 10 μm in thickness were
treated with 5 μM BTP3-Neu5Ac for 10 min. Clear green ﬂuores-
cence was observed inside bronchioles (BRs) in SV-infected lung
sections but not in lung sections from non-infected mice (Fig. 4A).
It has been reported that SV infects the bronchiolar epithelium
when mice are intranasally challenged with SV (Castleman et al.,
1987), coinciding with the staining site of BTP3-Neu5Ac in lungs of
SV-infected mice. To conﬁrm that the SV-infected bronchiolar
epithelium was speciﬁcally stained with BTP3-Neu5Ac, we com-
pared double-staining in SV-infected lung section with BTP3-
Neu5Ac and with a rabbit anti-SV polyclonal antibody. The
bronchiolar epithelium stained with BTP3-Neu5Ac was also
stained with anti-SV antibody (Fig. 4B). Co-localisation of the both
stainings indicated that BTP3-Neu5Ac speciﬁcally stained SV-
infected regions in tissues.
In the present study, we concluded that BTP3-Neu5Ac ﬂuores-
cently visualised SV sialidase activity and SV-infected regions
in vitro and in SV-infected mouse lung sections in a short time
(within several minutes), in addition to no requirement of speciﬁc
anti-SV antibodies.
Discussion and conclusion
We have developed a new ﬂuorescent sialidase substrate,
BTP3-Neu5Ac, which enables sensitive histochemical staining of
sialidase activity. In the present study, we were able to rapidly and
sensitively visualise the SV-infected cells with BTP3-Neu5Ac.
Normally, in order to histochemically stain SV-infected cells,
immunostaining with an anti-SV antibody would be the ﬁrst
choice in most cases. A speciﬁc anti-SV antibody and an enzyme-
or ﬂuorescence-conjugated secondary antibody must therefore be
prepared. Additionally, before primary antibody reaction, cells
must be ﬁxed and permeabilised with a detergent. Reaction times
with primary and secondary antibodies take at least 1 h (30 min
for each antibody) at room temperature (Fukushima et al., 2011).
Thus, it takes more than 1 h to complete immunostaining. How-
ever, when BTP3-Neu5Ac is used, live infected cells can be stained
in several minutes only (within 10 min) by an easy protocol to
exchange cultured supernatant into the substrate solution.
SV widely infects many cell lines and shows high cytotoxicity,
but it causes no clinical symptoms in humans (Castleman et al.,
1987). Reverse genetics system has been positioning SV as a
biotechnological tool (Segawa et al., 2003). Recently, recombinant
SV has been utilised as an oncolytic virus, as a vector in gene
therapy against Fabry's disease (Kawagoe et al., 2013) and Alzhei-
mer's disease (Iwasaki et al., 2012), and as a vaccinating vector
against respiratory syncytial virus (Jones et al., 2012), human
parainﬂuenza virus type 1 and type 3 (Faísca and Desmecht,
Fig. 2. Fluorescent visualisation of SV sialidase activity with BTP3-Neu5Ac. SV was
blotted onto a PVDF membrane. (A) Determination of optimal pH for viral sialidase
visualisation. (B) Fluorescent visualisation of SV blots with BTP3-Neu5Ac. The
indicated HAU of SV on a PVDF membrane was treated with BTP3-Neu5Ac. (C)
Visualisation of SV blots with X-Neu5Ac. The indicated HAU of SV on a PVDF
membrane was treated with X-Neu5Ac for 10 min or 24 h. (–) indicates that no
virus was blotted.
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2007; Mason et al., 2013; Sealy et al., 2010), and human immuno-
deﬁciency virus (Hara et al., 2011). For the purpose of easy
investigation of SV transfection efﬁcacy and actual infection, a
green ﬂuorescent protein (GFP) gene is often introduced into
recombinant SV genetically. The GFP should enable detection of
SV-transfected regions, but GFP insertion might decrease efﬁcient
virus proliferation (Agungpriyono et al., 2000). BTP3-Neu5Ac could
solve such a problem because it can histochemically visualise cells
or tissues infected with SV without the GFP gene in a short time.
SV research could spread more and more widely. A system for
more efﬁcient evaluation of SV transfection is essential. We expect
that BTP3-Neu5Ac will contribute to further development and
more rapid progress of SV studies such as virological sialidase
studies and studies to develop an oncolytic virus, a gene therapy
vector, and a vaccinating vector. BTP3-Neu5Ac could be an epoch-
making sialidase substrate in SV research, with no requirement of
cell or tissue ﬁxation and immunochemical reagents. As we
previously reported, BTP3-Neu5Ac derivatives are reactive to
mammalian (mouse, rat, and human) and bacterial sialidases
(Arthrobacter ureafaciens) (Minami et al., 2014), which means that
BTP3-Neu5Ac has a broad spectrum in sialidase reaction. In this
study, we focused on SV as a representative virus that has
sialidase. Under the conditions in the present study, BTP3-
Neu5Ac could be used for speciﬁcally staining SV-infected cells
without detection of endogenous mammalian sialidase because of
the short time reaction. We are now studying the usefulness of
BTP3-Neu5Ac for other viruses that have sialidase, such as New-
castle disease virus, human parainﬂuenza virus, mumps virus, and
inﬂuenza virus. We expect that BTP3-Neu5Ac will contribute to
further virological study in the future.
Materials and methods
Chemicals
BTP3-Neu5Ac was synthesised as previously described (Minami
et al., 2014). The following compounds were acquired from the
indicated vendors. X-Neu5Ac and DANA were purchased from
Fig. 3. Fluorescent histochemical visualisation of SV-infected cells with BTP3-Neu5Ac. LLC-MK2 cells were treated with BTP3-Neu5Ac in SFM (pH 4.5) at 37 1C for 5 min at
24 h post SV infection. (A) Cells were infected with SV at the indicated titre and treated with BTP3-Neu5Ac. (B) Cells were infected with SV with 1.4103 ffu/well and treated
with BTP3-Neu5Ac in the presence (right panel) or absence (left panel) of 1 mM DANA, a pan-sialidase inhibitor. (C) Visualisation of HNsv-expressing cells. Cos-7 cells
transfected with pCAGGS-HNsv and an empty vector were treated with BTP3-Neu5Ac at 48 h post transfection. (D) Double stainings of infected cells with BTP3-Neu5Ac and
anti-SV polyclonal antibody. The infected cells were ﬁxed with 4% paraformaldehyde and immunostained with a rabbit anti-SV antibody (red in right panel), followed by
BTP3-Neu5Ac (green in left panel). Scale bar¼100 mm.
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Peptide Industry Inc., Osaka, Japan, and Tokyo Chemical Industry,
Co., Ltd., Tokyo, Japan, respectively.
Cells and viruses
Lewis lung carcinoma-monkey kidney LLC-MK2 cells were
maintained in Eagle's minimum essential medium supplemented
with 5% foetal bovine serum (FBS). African monkey kidney Cos-7
cells were maintained in Dulbecco's modiﬁed Eagle's medium
supplemented with 10% FBS. SV (Z strain) was propagated in 11-
day-old embryonated chicken eggs and concentrated with glycerol
as described previously (Suzuki et al., 2001a; Suzuki et al., 2001b).
Antibodies
Rabbit anti-SV polyclonal antibody was prepared by immunisa-
tion of rabbits against SV according to previously described
method (Suzuki et al., 2001a). Horseradish peroxidase (HRP)-
conjugated Protein A (Sigma-Aldrich, St. Louis, MO) and phycoer-
ythrin (PE)-conjugated goat anti-rabbit IgG (Santa Cruz Biotech-
nology Inc., Dallas, TX) were purchased.
Hemagglutination unit determination
Fifty microliters/well of 2-fold serial dilutions of SV in
phosphate-buffered saline (PBS; pH 7.2, 131 mM NaCl, 14 mM
Na2HPO4, 1.5 mM KH2PO4, and 2.7 mM KCl) was poured into a U-
bottom 96-well plate. PBS was used as a negative control without
virus. Fifty microliters/well of 0.5% v/v human red blood cell
suspension in PBS was added. A plate was incubated at 4 1C for
2 h. The reciprocal of the highest SV dilution showing hemagglu-
tination was deﬁned as HAU.
Fig. 4. Histochemical visualisation of SV-infected region in mouse lung tissue with BTP3-Neu5Ac. Female BALB/c mice were challenged with SV at 1107 ffu/mouse. At 24 h
post infection, 10-mm-thick lung sections were prepared. First, the sections were treated with BTP3-Neu5Ac. Then the sections were immunostained with an anti-SV
polyclonal antibody. (A) Visualisation of SV-infected regions with BTP3-Neu5Ac in lung sections from SV-infected mouse (upper panel) and a non-infected mouse (lower
panel). (B) Lung sections from the SV-infected mouse were stained with BTP3-Neu5Ac (left panel) followed by staining with the anti-SV polyclonal antibody (right panel).
Scale bar¼100 mm. BR, bronchiole.
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Visualisation of dot-blotted SV on a membrane with BTP3-Neu5Ac or
X-Neu5Ac
In order to determine the proper pH of SV sialidase detectionwith
BTP3-Neu5Ac, a PVDF membrane was blotted with 2–1 HAU of SV in
200 μl/dot of PBS and incubated with 10 μM BTP3-Neu5Ac in 5 mM
acetate buffer (pH 4.5, 5.0, 5.5, or 6.0) at room temperature for
10 min. To compare the sensitivities of BTP3-Neu5Ac and X-Neu5Ac
against SV sialidase activity, PVDF membranes were each blotted
with 200 μl/dot of SV (2-fold serial dilutions from 22 HAU to 2–9
HAU) in PBS and incubated with 10 μM BTP3-Neu5Ac and 100 μM
X-Neu5Ac in 5 mM acetate buffer (pH 4.5) at room temperature for
10 min and 24 h, respectively. Images of the PVDF membranes were
obtained by using Lumi Vision PRO HR (AISIN SEIKI Co., Ltd., Aichi,
Japan) with DR655YA3 optical ﬁlter (Kenko Tokina Co., Ltd., Tokyo,
Japan) under ultraviolet (UV) irradiation or an optical condition.
Construction of a expression vector containing the HN gene
SV RNA was isolated from virus particles with TRIzol reagent
(Invitrogen Corp., Carsbad, CA) according to the manufacturer's
instructions. The full length of the HNsv gene (GenBank acces-
sion number M30202) was ampliﬁed with a TaKaRa RNA
PCR™ kit (AMV) ver. 3.0 (TaKaRa Bio Inc., Shiga, Japan) with
speciﬁc primers, 50–CGGAATTCCGTGAAAGTGAGGTCGCGCGGTAC-
TTTAGCTTT-30 and 50–CCATCGATGGCTTAATACTGTGAGAGACGTAA-
GAGACTGA-30. pCAGGS-HNsv was constructed by insertion of the
HNsv gene into the multicloning region between the EcoR I site and
Cla I site of expression plasmid pCAGGS/MCS vector (Takahashi et al.,
2010).
Fluorescent visualisation of HNsv-expressing cells with BTP3-Neu5Ac
A 70% conﬂuent monolayer of Cos-7 cells on a 48-well plate was
transfected with pCAGGS-HNsv (300 ng/well) using the transfection
reagent TransIT-LT1 (Mirus, Madison, WI) according to manufac-
turer's instructions. pCAGGS/MCS was used as a negative control.
After incubation at 37 1C in 5% CO2 for 4 h, cells were washed with
PBS and cultured in a serum-free medium (SFM), Hybridoma-SFM
(Invitrogen Corp, Carlsbad, CA), for 44 h at 37 1C in 5% CO2. Cells were
washed with PBS and treated with 10 μM BTP3-Neu5Ac in 100 μl/
well of SFM (adjusted to pH 4.5 with 3 N HCl) at 37 1C in 5% CO2 for
5 min. Cells were washed with PBS and observed with an IX71
ﬂuorescent microscope (Olympus Co., Ltd., Tokyo, Japan) equipped
with a ﬂuorescent ﬁlter (U-MWU2, DM400, BP336-385, BA420).
Determination of focus-forming units
A conﬂuent monolayer of LLC-MK2 cells on a 12-well plate was
infected with 10-fold serially diluted SV in SFM at room tempera-
ture for 1 h, followed by addition of an overlay medium containing
1.2% Avicels RC-581 NF (FMC Biopolymer, Philadelphia, PA) in
SFM. The cells were cultured for 48 h at 37 1C in 5% CO2. After
removal of the overlay medium, the cells were washed 3 times
with PBS and ﬁxed with methanol. The infected cells (foci) were
visualised immunologically with rabbit anti-SV serum, and the
number was counted to determine focus-forming units (ffu).
Fluorescent visualisation of SV-infected cells with BTP3-Neu5Ac
A conﬂuent monolayer of LLC-MK2 cells on a 96-well plate was
infected with the indicated ffu of SV in 45 μl/well of SFM at 37 1C
in 5% CO2 for 1 h and washed with 100 μl/well of PBS. After culture
in 100 μl/well of SFM at 37 1C in 5% CO2 for 24 h, cells were stained
with 10 μM BTP3-Neu5Ac in 45 μl of SFM (pH 4.5) at 37 1C in 5%
CO2 for 5 min. To conﬁrm sialidase dependency of ﬂuorescent
staining with BTP3-Neu5Ac, cells were also stained with 10 μM
BTP3-Neu5Ac in 45 μl of SFM (pH 4.5) at 37 1C in 5% CO2 for 5 min
in the presence of 1 mM DANA, a pan-sialidase inhibitor. Then the
cells were washed with 100 μl/well of PBS and observed in 100 μl/
well of SFM by using a ﬂuorescent microscope.
Immunostaining of SV-infected cells
In order to conﬁrm that BTP3-Neu5Ac speciﬁcally stained SV-
infected cells, infected cells were immunostained with a rabbit anti-
SV polyclonal antibody. A conﬂuent monolayer of LLC-MK2 cells on
a 96-well plate were infected with the indicated ffu of SV in 45 μl/
well of SFM at 37 1C in 5% CO2 for 1 h, washed with 100 μl/well of
PBS, and cultured in 100 μl/well of SFM at 37 1C in 5% CO2 for 24 h.
Cells were ﬁxed with 4% paraformaldehyde (Wako Pure Chemical
Industries Ltd, Osaka, Japan) at room temperature for 10 min and
washed with PBS. The cells were treated with a rabbit anti-SV
polyclonal antibody in PBS, followed by PE-conjugated goat anti-
rabbit IgG at room temperature for 30 min each. Then cells were
incubated with 10 μM BTP3-Neu5Ac in 45 μl/well of SFM (pH 4.5)
at 37 1C in 5% CO2 for 30 min and washed with PBS. Immunohis-
tochemical images of the infected cells were observed using a
ﬂuorescent microscope equipped with ﬂuorescent ﬁlter (U-MWIG3,
DM570, BP530–550, BA575IF).
Fluorescent histochemical staining of SV-infected mouse lungs
with BTP3-Neu5Ac
Mice were infected according to a previous report (Bousse
et al., 2002). Brieﬂy, 6–8-week-old female BALB/c mice were
intranasally infected with 1107 ffu of SV in 20 μl/mouse of
PBS. At 24 hr postinfection, lungs were collected, treated with 4%
paraformaldehyde in PBS, and embedded into Tissue-Tek OCT
compound (Sakura Finetechnical Co., Ltd., Tokyo, Japan). After
being frozen, lungs were cut in 10-μm-thick sections at 20 1C
with a Shandon Cryotome FE (Thermo Fisher Scientiﬁc, Waltham,
MA) and ﬁxed with 4% paraformaldehyde for 15 min. Sections
were stained with 50 μl/section of 5 μM BTP3-Neu5Ac in 10 mM
acetate buffer (pH 4.5) at 37 1C for 10 min and washed with PBS.
The sections were observed by using a ﬂuorescent microscope.
Immunohistochemical staining of SV-infected mouse lungs
To conﬁrm SV antigen-positive regions, lung sections were
immunostained with a rabbit anti-SV polyclonal antibody. Sections
were blocked with 2% goat serum at 4 1C overnight and washed
with PBS. The sections were incubated with a rabbit anti-SV
polyclonal antibody in 0.2% goat serum in PBS and then with
HRP-conjugated Protein A in 0.2% goat serum in PBS at room
temperature for 30 min each. Infected regions were visualised as
described previously (Suzuki et al., 2001a; Suzuki et al., 2001b;
Takahashi et al., 2010).
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